<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Phys.Org news tagged with: oncology</title>
<link>http://phys.org/</link>
<language>en-us</language> 
<description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Lower levels of key protein influence tumor growth in mice, study shows</title>
   	 <description>Tumors need a healthy supply of blood to grow and spread. Researchers at the Stanford University School of Medicine have identified a molecule that regulates blood vessel growth that is often found at less-than-normal levels in human tumors. Blocking the expression of the molecule, called PHD2, allows human cancer cells to grow more quickly when implanted into mice and increases the number of blood vessels feeding the tumor.</description>
     <link>http://phys.org/news163084699.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Jun 2009 14:19:16 EST</pubDate>
	 <guid isPermaLink="false">news163084699</guid>
	 
</item>
<item>
     <title>Study: Cancer survivors not getting needed tests</title>
   	 <description>(AP) --  New research finds that people who had radiation treatments for cancer as children are less likely than the general public or even their healthy siblings to get recommended screening tests.</description>
     <link>http://phys.org/news163072496.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Jun 2009 10:55:34 EST</pubDate>
	 <guid isPermaLink="false">news163072496</guid>
	 
</item>
<item>
     <title>Cancer researchers first to link intestinal inflammation with systemic chromosome damage</title>
   	 <description>(PhysOrg.com) -- UCLA scientists have linked for the first time intestinal inflammation with systemic chromosome damage in mice, a finding that may lead to the early identification and treatment of human inflammatory disorders, some of which increase risk for several types of cancer.</description>
     <link>http://phys.org/news163044358.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Jun 2009 03:06:22 EST</pubDate>
	 <guid isPermaLink="false">news163044358</guid>
	 
</item>
<item>
     <title>US cancer care: treatment choices are all about you</title>
   	 <description> US cancer experts are preparing to focus on new developments in making treatment ever more personalized, right down to the molecular level, at their main annual gathering this weekend.</description>
     <link>http://phys.org/news162821483.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 29 May 2009 13:12:52 EST</pubDate>
	 <guid isPermaLink="false">news162821483</guid>
	 
</item>
<item>
     <title>New study finds dramatic increase in metastatic colon cancer survival</title>
   	 <description>Novel chemotherapy and biological agents for metastatic colorectal cancer, combined with surgical advances in liver resection, have resulted in a dramatic increase in survival for patients with advanced disease, according to researchers at The University of Texas M. D. Anderson Cancer Center.</description>
     <link>http://phys.org/news162579680.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 26 May 2009 18:01:47 EST</pubDate>
	 <guid isPermaLink="false">news162579680</guid>
	 
</item>
<item>
     <title>Green tea extract shows promise in leukemia trials</title>
   	 <description>Mayo Clinic researchers are reporting positive results in early leukemia clinical trials using the chemical epigallocatechin gallate (EGCG), an active ingredient in green tea. The trial determined that patients with chronic lymphocytic leukemia (CLL) can tolerate the chemical fairly well when high doses are administered in capsule form and that lymphocyte count was reduced in one-third of participants. The findings appear today online in the Journal of Clinical Oncology.</description>
     <link>http://phys.org/news162578349.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 26 May 2009 17:41:23 EST</pubDate>
	 <guid isPermaLink="false">news162578349</guid>
	 
</item>
<item>
     <title>Less Toxic Drug Prolongs Survival in Metastatic Breast Cancer</title>
   	 <description>(PhysOrg.com) -- Research from the Northwestern University Feinberg School of Medicine has found that a less toxic, solvent-free chemotherapy drug more effectively prevents the progression of metastatic breast cancer and has fewer side effects than a commonly used solvent-based drug.</description>
     <link>http://phys.org/news162572989.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 26 May 2009 16:10:27 EST</pubDate>
	 <guid isPermaLink="false">news162572989</guid>
	 
</item>
<item>
     <title>Long-term study shows low oxygen levels in prostate tumors can predict recurrence</title>
   	 <description>Fox Chase Cancer Center researchers have discovered that low-oxygen regions in prostate tumors can be used to predict a rise in prostate-specific antigen (PSA) levels, a marker of tumor recurrence in prostate cancer. The long-term study results will be presented at the 2009 American Society of Clinical Oncology annual meeting in Orlando, FL.</description>
     <link>http://phys.org/news161629517.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 15 May 2009 18:05:36 EST</pubDate>
	 <guid isPermaLink="false">news161629517</guid>
	 
</item>
<item>
     <title>Study first to evaluate prevalence, impact of off label chemotherapy in breast cancer</title>
   	 <description>At some point during their care, more than one-third of metastatic breast cancer patients receive chemotherapy off label, the legal use of FDA-approved drugs in a different indication than for which they were approved, according to researchers at The University of Texas M. D. Anderson Cancer Center.</description>
     <link>http://phys.org/news161610244.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 15 May 2009 12:48:17 EST</pubDate>
	 <guid isPermaLink="false">news161610244</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/mdandersonst.jpg" width="90" height="129" />
</item>
<item>
     <title>Mothers satisfied when they share cancer genetic test results with children</title>
   	 <description>Mothers who share cancer genetic test results with their children are more satisfied with their decision than those who decide not to tell, according to a new study by researchers at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center.  The study also shows, for the first time, what role fathers play in disclosing mother's test results.  These findings will be presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando May 29 - June 2.</description>
     <link>http://phys.org/news161544198.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 14 May 2009 18:23:43 EST</pubDate>
	 <guid isPermaLink="false">news161544198</guid>
	 
</item>
<item>
     <title>Almost 30 percent of cancer studies report conflict of interest</title>
   	 <description>A new analysis finds that a considerable number of clinical cancer studies published in respected medical journals have financial connections to pharmaceutical companies. Published in the June 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that conflicts of interest may cause some researchers to report biased results that are favorable to companies.</description>
     <link>http://phys.org/news161229233.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 11 May 2009 02:56:32 EST</pubDate>
	 <guid isPermaLink="false">news161229233</guid>
	 
</item>
<item>
     <title>Exercise programs may improve symptoms in non-small cell lung cancer patients</title>
   	 <description>Exercise is known to have a positive effect on maintaining a healthy lifestyle, and a study in the May issue of the Journal of Thoracic Oncology has shown that exercise also plays an important role in both primary and secondary prevention of cancer. </description>
     <link>http://phys.org/news160661826.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 04 May 2009 13:18:37 EST</pubDate>
	 <guid isPermaLink="false">news160661826</guid>
	 
</item>
<item>
     <title>Type of lung cancer screening used to detect disease may impact 5-year survival rates</title>
   	 <description>Dr. Hisao Asamura and his team of researchers at The National Cancer Center Hospital in Tokyo, Japan examined the records of 2,281 patients who underwent lung cancer resection surgery between 2000 and 2006. The study was published in the May issue of the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer. Dr. Asamura and his team found that after classifying patients based on the technique used to diagnose their lung cancer, eithe</description>
     <link>http://phys.org/news160660791.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 04 May 2009 13:02:29 EST</pubDate>
	 <guid isPermaLink="false">news160660791</guid>
	 
</item>
<item>
     <title>Lithium may help radiation target cancer, spare healthy tissue</title>
   	 <description>Vanderbilt-Ingram Cancer Center investigators have uncovered a mechanism that helps explain how lithium, a drug widely used to treat bipolar mood disorder, also protects the brain from damage that occurs during radiation treatments.</description>
     <link>http://phys.org/news160660640.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 04 May 2009 12:57:49 EST</pubDate>
	 <guid isPermaLink="false">news160660640</guid>
	 
</item>
<item>
     <title>African-American women still have poorer breast cancer outcomes</title>
   	 <description>New research published in the May issue of the Journal of the American College of Surgeons shows that dramatic disparities in breast cancer outcomes continue to exist for African-American women, regardless of the age at which they are diagnosed, extent of the cancer, type of treatment or socioeconomic status. The study represents the largest population-based analysis of breast cancer outcomes data to date, including more than 60,000 patients in the state of Florida.</description>
     <link>http://phys.org/news160653818.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 04 May 2009 11:04:42 EST</pubDate>
	 <guid isPermaLink="false">news160653818</guid>
	 
</item>
<item>
     <title>Personalized treatment for early lung cancer</title>
   	 <description>Cancer vaccines and targeted therapies are beginning to offer new treatment options following surgery for patients with early stages of lung cancer, experts said at the first European Multidisciplinary Conference in Thoracic Oncology (EMCTO) in Lugano, Switzerland (1-3 May 2009).</description>
     <link>http://phys.org/news160593252.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 03 May 2009 18:14:59 EST</pubDate>
	 <guid isPermaLink="false">news160593252</guid>
	 
</item>
<item>
     <title>Radiation device in the breast reduces complications for early stage breast cancer patients</title>
   	 <description>A new study shows that the SAVI applicator, a small, expandable device inserted inside the breast to deliver partial breast irradiation, carries a low infection risk, a potential complication of such devices. The research, led by radiation oncologists and surgeons at the Moores UCSD Cancer Center and Fort Myers, Florida-based 21st Century Oncology, also indicates that other complications - such as seromas, pockets of fluid that build with the use of internal radiation devices - are unlikely to occur.</description>
     <link>http://phys.org/news159729540.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 23 Apr 2009 18:21:14 EST</pubDate>
	 <guid isPermaLink="false">news159729540</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/1-radiationdev.jpg" width="90" height="45" />
</item>
<item>
     <title>Study links arm/hand swelling to number of lymph nodes removed during breast cancer surgery</title>
   	 <description>In older breast cancer survivors, the number of lymph nodes removed during surgery and the presence of cancer in the lymph nodes were the two factors most directly linked to the development of lymphedema, swelling of the arm and hand, according to a study from the Medical College of Wisconsin's Center for Patient Care and Outcomes Research in Milwaukee, Wisconsin.</description>
     <link>http://phys.org/news159707077.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 23 Apr 2009 12:04:53 EST</pubDate>
	 <guid isPermaLink="false">news159707077</guid>
	 
</item>
<item>
     <title>Developmental drug helps protect against radiation damage</title>
   	 <description>A drug currently under development at the University of Pittsburgh School of Medicine protects cells from the damaging effects of radiation exposure, a new study suggests. Results of the study, Abstract Number 3988, are being presented at the 100th annual meeting of the American Association for Cancer Research (AACR), April 18 to 22 in Denver.</description>
     <link>http://phys.org/news159634731.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 22 Apr 2009 15:59:43 EST</pubDate>
	 <guid isPermaLink="false">news159634731</guid>
	 
</item>
<item>
     <title>New treatment shows promise against recurrent gynecologic cancers</title>
   	 <description>(BRONX, NY) - Recurrent and metastatic endometrial and ovarian cancers can be notoriously difficult to treat: They have spread to other organs and typically have developed resistance to chemotherapy; and patients already heavily treated with chemotherapy may not be able to endure more chemo. Now, physicians at Albert Einstein College of Medicine of Yeshiva University have shown that a combination of two chemotherapy drugs not only produced clinical benefit for such patients but were also well tolerated. The findings are published online in the journal Gynecologic Oncology.</description>
     <link>http://phys.org/news159558309.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 21 Apr 2009 18:46:14 EST</pubDate>
	 <guid isPermaLink="false">news159558309</guid>
	 
</item>
<item>
     <title>Predicting patient response to gleevec in gastrointestinal stromal tumors</title>
   	 <description>Researchers at  Fox Chase Cancer Center uncovered a genetic pattern that may help predict how gastrointestinal stromal tumor (GIST) patients respond to the targeted therapy imatinib mesylate (Gleevec).  Moreover, their findings point to genes that could be suppressed in order to make these tumors respond more readily to imatinib.</description>
     <link>http://phys.org/news159545054.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 21 Apr 2009 15:04:36 EST</pubDate>
	 <guid isPermaLink="false">news159545054</guid>
	 
</item>
<item>
     <title>Hypofractionated stereotactic radiotherapy beneficial for recurrent low-grade glioma</title>
   	 <description>Hypofractionated stereotactic radiotherapy was well-tolerated and improved symptoms in patients with recurrent low-grade glioma, according to researchers from the Kimmel Cancer Center at Jefferson. The data were presented at the AACR 100th Annual Meeting 2009.</description>
     <link>http://phys.org/news159542301.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 21 Apr 2009 14:18:44 EST</pubDate>
	 <guid isPermaLink="false">news159542301</guid>
	 
</item>
<item>
     <title>Personalized medicine helps cancer patients survive</title>
   	 <description>Cancer patients can survive longer under treatments based on their individual genetic profiles, according to a nationwide study released jointly today by Phoenix-area healthcare organizations.</description>
     <link>http://phys.org/news159426847.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Apr 2009 06:16:59 EST</pubDate>
	 <guid isPermaLink="false">news159426847</guid>
	 
</item>
<item>
     <title>Penn's online survivorship care plans empower cancer survivors, caregivers</title>
   	 <description>An online tool that provides cancer survivors and their family members with an easy-to-follow roadmap for managing their health as they finish treatment and transition to life as a survivor got high marks from users, according to new University of Pennsylvania School of Medicine research which will be presented this weekend at the American Association for Cancer Research (AACR) 100th Annual Meeting 2009 in Denver. Ninety-seven percent of people who used OncoLife, the first online cancer survivorship care plan tool - developed by physicians and nurses from Penn's Abramson Cancer Center - rated their experience with the tool as &quot;good&quot; to &quot;excellent,&quot; and 84 percent said they planned to share their plan with their health care team.</description>
     <link>http://phys.org/news159374663.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 19 Apr 2009 15:44:56 EST</pubDate>
	 <guid isPermaLink="false">news159374663</guid>
	 
</item>
<item>
     <title>New minimally invasive surgery option for patients with stomach cancer</title>
   	 <description>A novel, minimally invasive surgical approach to treat stomach cancer has been shown to have advantages that may make it a preferable treatment for some patients.</description>
     <link>http://phys.org/news159037741.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 15 Apr 2009 18:09:33 EST</pubDate>
	 <guid isPermaLink="false">news159037741</guid>
	 
</item>
<item>
     <title>Veterinary oncologists advance cancer drugs for humans and pets</title>
   	 <description>As more pet owners are choosing to treat their pets' cancers through advanced medicine, veterinarians gain valuable knowledge about the progression and treatment of cancers in humans through pet trials of new drugs. To help organize nationwide trials in tumor-bearing dogs using cancer drugs, the National Cancer Institute has launched the Comparative Oncology Trials Consortium (COTC). Faculty members in the University of Missouri's Scott Endowed Program in Veterinary Oncology participated in COTC's first trial.</description>
     <link>http://phys.org/news159031096.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 15 Apr 2009 16:18:49 EST</pubDate>
	 <guid isPermaLink="false">news159031096</guid>
	 
</item>
<item>
     <title>Study suggests that trouble sleeping leads to increased ratings of pain in cancer patients</title>
   	 <description>A study in the April 15 issue of the Journal of Clinical Sleep Medicine suggests that sleep problems lead to increased pain and fatigue in cancer patients. The results indicate that interventions aimed at trouble sleeping would be expected to improve both pain and fatigue in this patient population.</description>
     <link>http://phys.org/news158992653.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 15 Apr 2009 05:38:41 EST</pubDate>
	 <guid isPermaLink="false">news158992653</guid>
	 
</item>
<item>
     <title>More women with early-stage breast cancer choosing double mastectomies</title>
   	 <description>A University of Minnesota cancer surgeon and researcher has found a dramatic increase in the number of women diagnosed with the earliest stage of breast cancer choosing to have both breasts surgically removed.</description>
     <link>http://phys.org/news158493613.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 09 Apr 2009 11:00:44 EST</pubDate>
	 <guid isPermaLink="false">news158493613</guid>
	 
</item>
<item>
     <title>High-dose radiation improves lung cancer survival</title>
   	 <description>Higher doses of radiation combined with chemotherapy improve survival in patients with stage III lung cancer, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.</description>
     <link>http://phys.org/news158409811.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 08 Apr 2009 11:44:02 EST</pubDate>
	 <guid isPermaLink="false">news158409811</guid>
	 
</item>
<item>
     <title>Study finds pre-surgical stress management improves mood, quality of life</title>
   	 <description>Brief stress management sessions prior to and immediately after surgery may have both short- and long-term benefit for men undergoing a radical prostatectomy for early-stage prostate cancer, according to research from The University of Texas M. D. Anderson Cancer Center.</description>
     <link>http://phys.org/news158258694.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 06 Apr 2009 17:45:52 EST</pubDate>
	 <guid isPermaLink="false">news158258694</guid>
	 
</item>


</channel>
</rss>
